Total Payments
$16,944
2023 Payments
$16,135
Companies
11
Transactions
35
Medicare Patients
1,999
Medicare Billing
$224,317
Payment Breakdown by Category
Consulting$10,895 (64.3%)
Travel$5,022 (29.6%)
Food & Beverage$1,013 (6.0%)
Education$14.16 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,895 | 1 | 64.3% |
| Travel and Lodging | $5,022 | 2 | 29.6% |
| Food and Beverage | $1,013 | 31 | 6.0% |
| Education | $14.16 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $16,099 | 6 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $369.18 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $157.80 | 5 | $0 (2019) |
| Genentech USA, Inc. | $98.55 | 8 | $0 (2017) |
| GlaxoSmithKline, LLC. | $81.01 | 3 | $0 (2023) |
| NxStage Medical, Inc. | $41.89 | 2 | $0 (2019) |
| UCB, Inc. | $27.91 | 2 | $0 (2017) |
| Exeltis, USA Inc. | $26.75 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $15.38 | 1 | $0 (2017) |
| Allergan Inc. | $14.56 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $16,135 | 6 | CSL Behring ($16,087) |
| 2022 | $26.75 | 1 | Exeltis, USA Inc. ($26.75) |
| 2019 | $139.82 | 4 | Mallinckrodt Enterprises LLC ($89.81) |
| 2018 | $295.10 | 4 | Mallinckrodt LLC ($174.50) |
| 2017 | $347.40 | 20 | Mallinckrodt LLC ($104.87) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/01/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $48.53 | General |
| 02/06/2023 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $10,895.00 | General |
| 01/27/2023 | CSL Behring | — | Food and Beverage | In-kind items and services | $105.52 | General |
| 01/26/2023 | CSL Behring | — | Travel and Lodging | In-kind items and services | $500.96 | General |
| 01/26/2023 | CSL Behring | — | Food and Beverage | In-kind items and services | $63.95 | General |
| 01/23/2023 | CSL Behring | — | Travel and Lodging | In-kind items and services | $4,521.37 | General |
| 04/19/2022 | Exeltis, USA Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 10/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.16 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2019 | Mallinckrodt Enterprises LLC | — | Food and Beverage | In-kind items and services | $89.81 | General |
| 03/13/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/09/2019 | NxStage Medical, Inc. | SYSTEM ONE (Device) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Nephrology | ||||||
| 10/03/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $88.41 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 07/09/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 05/21/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $86.09 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 05/16/2018 | NxStage Medical, Inc. | System One (Device) | Food and Beverage | Cash or cash equivalent | $20.60 | General |
| Category: Nephrology | ||||||
| 09/19/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Immunology | ||||||
| 09/18/2017 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Neurology | ||||||
| 09/13/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Immunology | ||||||
| 08/29/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: Immunology | ||||||
| 08/16/2017 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Immunology | ||||||
| 07/31/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Immunology | ||||||
| 06/27/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Immunology | ||||||
| 05/31/2017 | Genentech USA, Inc. | Esbriet (Biological) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Immunology | ||||||
| 05/24/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 373 | 495 | $154,946 | $43,667 |
| 2022 | 14 | 434 | 562 | $145,421 | $44,483 |
| 2021 | 13 | 451 | 581 | $161,951 | $49,693 |
| 2020 | 16 | 741 | 990 | $284,787 | $86,474 |
Total Patients
1,999
Total Services
2,628
Medicare Billing
$224,317
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 76 | 136 | $82,960 | $21,949 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 68 | $14,620 | $6,005 | 41.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 54 | $13,824 | $4,809 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 29 | $9,961 | $3,656 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $4,828 | $1,616 | 33.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 14 | 16 | $7,760 | $1,036 | 13.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 15 | $2,382 | $922.20 | 38.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 21 | 24 | $4,560 | $892.18 | 19.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 29 | 35 | $4,025 | $828.43 | 20.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 19 | 23 | $4,416 | $806.08 | 18.3% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 13 | 13 | $1,560 | $448.11 | 28.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 19 | 22 | $2,508 | $407.60 | 16.3% |
| 88738 | Hemoglobin measurement | Office | 2023 | 26 | 30 | $450.00 | $147.60 | 32.8% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 12 | 13 | $1,092 | $142.74 | 13.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 62 | 110 | $67,100 | $19,234 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 90 | $19,350 | $7,568 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 51 | 70 | $17,920 | $5,605 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $4,879 | $2,306 | 47.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 34 | 38 | $7,220 | $1,708 | 23.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 36 | 40 | $7,680 | $1,611 | 21.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,082 | $1,473 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,630 | $1,309 | 36.1% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 31 | 35 | $4,025 | $889.60 | 22.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 37 | 40 | $4,560 | $816.75 | 17.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $2,058 | $681.66 | 33.1% |
About Dr. Ogugua Obi, M.D
Dr. Ogugua Obi, M.D is a Pulmonary Disease healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477685360.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ogugua Obi, M.D has received a total of $16,944 in payments from pharmaceutical and medical device companies, with $16,135 received in 2023. These payments were reported across 35 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($10,895).
As a Medicare-enrolled provider, Obi has provided services to 1,999 Medicare beneficiaries, totaling 2,628 services with total Medicare billing of $224,317. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Internal Medicine
- Location Greenville, NC
- Active Since 03/09/2007
- Last Updated 02/23/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1477685360
Products in Payments
- ACTHAR (Biological) $279.37
- Esbriet (Biological) $72.91
- OFEV (Drug) $43.64
- NUCALA (Biological) $32.48
- Vimpat (Drug) $27.91
- PURIFIED CORTROPHIN GEL (Drug) $26.75
- Xolair (Biological) $25.64
- SYSTEM ONE (Device) $21.29
- System One (Device) $20.60
- XOLAIR (Biological) $15.38
- AVYCAZ (Drug) $14.56
- SPIRIVA RESPIMAT (Drug) $14.16
- UTIBRON (Drug) $12.84
- Berinert 500U (Biological) $11.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Greenville
Sean Callahan, M.d, M.D
Pulmonary Disease — Payments: $232,036
Pulmonary Disease $232,036
Michael Kaster, M.d, M.D
Pulmonary Disease — Payments: $11,043
Pulmonary Disease $11,043
Dr. Zia Rehman, Md, MD
Pulmonary Disease — Payments: $10,093
Pulmonary Disease $10,093
Ezzat El-Bayoumi, Md, MD
Pulmonary Disease — Payments: $8,838
Pulmonary Disease $8,838
Armin Meyer, M.d, M.D
Pulmonary Disease — Payments: $8,226
Pulmonary Disease $8,226
Dr. Minerva Covarrubias, Md, MD
Pulmonary Disease — Payments: $8,076
Pulmonary Disease $8,076